Sort   by:  
 Page size 
UnknownRandomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.
Not available
S-EPMC4239304 | biostudies-literature
TranscriptomicsTreponema denticola gene expression during co-culture with Porphyromonas gingivalis
Porphyromonas gingivalis and Treponema denticola are periodontalpathogens that are associated with the severity and progression of periodontal diseases. this study investigates the gene expression of Treponema denticola during co-culture with Porphyromonas gingivalis.
ORGANISM(S): Treponema denticola 
2014-03-31 | E-MTAB-2257 | biostudies-arrayexpress
TranscriptomicsPorphyromonas gingivalis gene expression during co-culture with Treponema denticola
Porphyromonas gingivalis and Treponema denticola are periodontalpathogens that are associated with the severity and progression of periodontal diseases. This study investigates the gene expression of Porphyromonas gingivalis during co-culture with Treponema denticola
ORGANISM(S): Porphyromonas gingivalis 
2014-03-31 | E-MTAB-2214 | biostudies-arrayexpress
UnknownLeukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma.
Not available
S-EPMC9790739 | biostudies-literature
UnknownDistribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Not available
S-EPMC7300910 | biostudies-literature
UnknownCutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients.
Not available
S-EPMC8441838 | biostudies-literature
UnknownA novel proangiogenic B cell subset is increased in cancer and chronic inflammation.
Not available
S-EPMC7220305 | biostudies-literature
GenomicsMulti-regional tumour biopsies of a RET fusion patient
Identifying modes of resistance to a new experimental drug for a patient resistant to other therapies
EGAS00001004023 | EGA
Genomics4dbf9af0-d667-494b-b3d9-c80c112d0527 - samples
high depth WGS sequencing of 8 sites of a RET fusion tumour
EGAD00001006878 | EGA
Genomicsdc7d6e29-28d7-43ec-895c-d530c18112cf - samples
Deep WGS sequencing (160x) of 2 different sites of disease of a patient with a RET fusion positive cancer. Amplicon sequencing of 19 other sites of the same patients for the RET fusion.
EGAD00001005776 | EGA
Sort   by:  
 Page size